Search PubMed⌕ Search

Biomedical subjects

G Kardos

Publications and source records attributed to G Kardos.

At least 73 records · Page 4Linked to original sources

Leukaemia in children with Down's syndrome.

Between 1971 and 1981 756 children were diagnosed to have leukaemia in Hungary. Of these, 17 had Down's syndrome. Analyzing the clinical course of their leukaemia revealed a low remission rate and very poor survival in these patients. Down's syndrome seems to present a special high-risk feature, for early death or relapse into leukaemia, which is only partially explained by the accompanying abnormalities.

Blood Cell Count↗

Late effects of therapy in children previously treated for leukaemia or malignant tumour.

The late sequelae of leukaemia and tumour therapy are discussed. The most important and/or the most frequent are neuro-psychologic disturbances, deformities of the bones, the decreased reproduction capacity and the second tumours. Because of the rapidly growing number of cured patients a better knowledge of the occurrence, aetiology, prophylaxis and rehabilitation of these changes is needed.

Adolescent↗

Infant leukemia in Hungary.

The treatment of childhood leukemia in Hungary is carried out in the framework of a national multicenter study. During the past ten years 633 newly diagnosed patients were treated in one of the ten centers. Of these, 39 were less than a year old at the time of diagnosis; 24 presented with ALL, 12 with AML, and three were found to have juvenile CML. Initial WBC count, which is the most important prognostic factor in childhood leukemia, was significantly higher in infants than in older children. Accordingly, the treatment results in these patients were inferior to those in children. Therapy of leukemia in infants remains a serious problem and warrants further studies to establish the best approach.

Antineoplastic Agents↗

The treatment of childhood leukaemia in Hungary. On behalf of the Hungarian Working Party on Childhood Leukaemia.

Children suffering from leukaemia in Hungary are treated according to uniform therapeutic protocols in the framework of a national multi-centre study. Their most important clinical data are stored in the central registry and are analyzed by computerized methods. Since January, 1971, 846 new patients were entered in the registry. Initially treatment results were very poor but showed gradual improvement during the past few years, somewhat parallel to more intensive chemotherapy. The latest treatment protocol includes medium-dose MTX and the combination of ARA-C and VM-26. Preliminary data are encouraging.

Actuarial Analysis↗

Changes in cardiac function in the "preclinical" stage of alcoholic heart disease.

In 103 out of 220 alcoholics (46.8%) with no heart disease electrocardiographic abnormalities were found, sinus tachycardia, T-wave irregularities and intraventricular conduction disturbances being the most common features. Comparing 138 chronic alcoholics with those of 134 healthy abstainers for the systolic time-intervals, the following abnormalities were found in the former group: prolonged PEP and ICT, shortened LVET, increased PEP/LVET and heart rate. Correction of the time intervals for heart-rate left the direction of the changes unaffected. Nor was the age of the subjects found to affect the intervals to any significant degree either in the alcoholics or in the control group. It is therefore assumed that the effect of alcohol on the time-intervals operates through at least two mechanisms, an increase in heart-rate, and a depression of myocardial contractility.

Adult↗

The fetal alcohol syndrome: symptoms and pathogenesis.

The symptoms of the fetal alcohol syndrome and their frequency of appearance are described based on 41 reports in the literature and on own observations. Experimental evidence is presented proving the lack of cytotoxicity, mutagenicity and teratogenicity of alcohol itself and the intensive cytotoxicity, mutagenicity and teratogenicity of acetaldehyde. Responsibility for the fetal alcohol syndrome is ascribed to acetaldehyde at maternal blood concentrations surpassing 35 micrometer and it is suggested that the raised acetaldehyde level is due to an inherited or acquired defect of mitochondrial aldehyde dehydrogenase. Prospective mothers displaying acetaldehyde levels exceeding 30 micrometer after a drink should be advised against bearing a child.

Abnormalities, Drug-Induced↗